38104-45-9

Basic information

• Product Name: 4H-1,2,4-Triazole-3,4-diamine
• Synonyms: 4H-1,2,4-Triazole-3,4-diamine
• CAS NO: 38104-45-9
• Molecular Formula: C₂H₅N₅
• Molecular Weight: 0
• Mol File: 38104-45-9.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 388.5°Cat760mmHg
• Flash Point: 188.7°C
• Appearance: /
• Density: 2g/cm³
• Vapor Pressure: 3.06E-06mmHg at 25°C
• Refractive Index: 1.903
• CAS DataBase Reference: 4H-1,2,4-Triazole-3,4-diamine(CAS DataBase Reference)
• NIST Chemistry Reference: 4H-1,2,4-Triazole-3,4-diamine(38104-45-9)
• EPA Substance Registry System: 4H-1,2,4-Triazole-3,4-diamine(38104-45-9)

Safety Data

• Hazardous Substances Data: 38104-45-9(Hazardous Substances Data)

Usage

InChI:InChI=1/C2H5N5/c3-2-6-5-1-7(2)4/h1H,4H2,(H2,3,6)

Upstream product

• 64-18-6 formic acid 
• 10308-83-5 N,N'-diamino-guanidine; nitrate 
• 6421-05-2 3,4-diamino-4H-1,2,4-triazole hydrochloride 
• 23160-99-8 3,4-diamino-1,2,4-triazole hydrobromide 
• 3529-50-8 4,5-diamino-2,4-dihydro-[1,2,4]triazole-3-thione 

Downstream Products

• 1491137-09-7 C₂H₅N₅*C₂H₂N₄O₃ 
• 71347-46-1 7-(2-chloro-phenyl)-[1,2,4]triazolo[4,3-b][1,2,4]triazine 
• 71347-44-9 7-(4-fluoro-phenyl)-[1,2,4]triazolo[4,3-b][1,2,4]triazine 
• 37160-06-8 6,7-diphenyl-[1,2,4]triazolo[4,3-b][1,2,4]triazine 
• 141228-31-1 4-(5,6-dihydro-7H-1,2,4-triazolo<4,3-b>-1,2,4-triazol-6-ylidene)-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one 
• 71347-45-0 7-(3-trifluoromethyl-phenyl)-[1,2,4]triazolo[4,3-b][1,2,4]triazine 
• 71347-43-8 7-(4-methoxy-phenyl)-[1,2,4]triazolo[4,3-b][1,2,4]triazine 

Relevant articles and documents

Syntheses, crystal structures and thermal analyses of two new ionic complexes based on 3,4-diamino-1,2,4-triazole

Two new ionic complexes, (DATr)2[Li2(TNR)2·2H2O]·2H2O (1) and (DATr)[Zn(DATr)Cl3] (2), were synthesized by using 3,4-diamino-1,2,4-triazole (DATr) as outer cation. X-ray single-crystal diff

Synthesis, characterization, and thermal analysis of two energetic Ionic Salts based on 3,4-Diamino-1,2,4-triazole (DATr)

Two energetic ionic salts DATr·NTO (2) and DATr·TNR (3) of 3,4-diamino-1,2,4-triazole (DATr) (1) were synthesized by reaction of 3,4-diamino-1,2,4-triazole with either 3-nitro-1,2,4-triazole-5-one (NTO) or 2,4,6-trinitro-resorcinol (TNR) in aqueous soluti

Heteropolycyclic inhibitors of protein kinases

A compound of the formula wherein, independently at each occurrence, v, w, and x are selected from C, N, O, and S, with H substitution as needed to fulfill open valence sites; y and z are selected from N and C, with H substitution as needed to fulfill open valence sites, with the proviso that each of w, v, x, y and z is not simultaneously C; the ring formed from v, w, x, y and z may be saturated or unsaturated; and R1, R2, R3 and R4 are selected from hydrogen, alkyl, aryl, alkaryl, aralkyl, heteroalkyl, and heteroaryl; wherein any adjacent two of R1, R2, R3 and R4 may join together to form a 5, 6 or 7-membered carbocyclic or heterocyclic ring, with the proviso that each of R1, R2, R3 and R4 is not simultaneously hydrogen. Pharmaceutical compositions of said compounds, and methods of use in the treatment of biological conditions including cellular hyperproliferation, are disclosed.